Regeneron Pharmaceuticals | REGN - Market Capitalization

Regeneron Pharmaceuticals reported $83.24B in Market Capitalization this March of 2023, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Market Capitalization Change
Abbvie ABBV:US USD 285.8B 48.51B
Agenus AGEN:US USD 732M 151M
Agios Pharmaceuticals AGIO:US USD 1.54B 7M
Alimera Sciences ALIM:US USD 36M 2M
Alnylam Pharmaceuticals ALNY:US USD 29.24B 4.62B
Amgen AMGN:US USD 140.14B 19.78B
Astellas Pharma 4503:JP JPY 3.63T 111.69B
AstraZeneca AZN:LN USD 173.83B 19.74B
Biogen BIIB:US USD 39.88B 774M
Biomarin Pharmaceutical BMRN:US USD 19.23B 3.51B
Bluebird Bio BLUE:US USD 488M 192M
Bristol Myers Squibb BMY:US USD 152.98B 1.18B
Eli Lilly And LLY:US USD 347.61B 40.37B
Esperion Therapeutics ESPR:US USD 459M 13M
Gilead Sciences GILD:US USD 107.68B 30.32B
GlaxoSmithKline GSK:LN GBP 58.86B 5.75B
Intercept Pharmaceuticals ICPT:US USD 512M 62M
IONIS PHARMACEUT IONS:US USD 5.36B 913M
Johnson & Johnson JNJ:US USD 461.85B 32.35B
Kyowa Hakko Kirin 4151:JP JPY 1.63T 159.3B
Merk MRK:US USD 281.3B 63.14B
Moderna Inc MRNA:US USD 69.01B 22.75B
Neurocrine Biosciences NBIX:US USD 11.48B 1.32B
Novartis NOVN:VX USD 200.93B 19.37B
Novartis NVS:US USD 217.36B 33.38B
Ophthotech OPHT:US USD 2.91B 795M
Opthea Ltd OPT:AU USD 425.04M 37.67M
Pfizer PFE:US USD 287.63B 42.03B
Puma Biotechnology PBYI:US USD 194M 86M
Regeneron Pharmaceuticals REGN:US USD 78.57B 3.48B
Roche Holding ROG:VX CHF 242.39B 20.72B
Sanofi SNY:US EUR 121.87B 24.49B
Sarepta Therapeutics SRPT:US USD 11.38B 1.7B
Seattle Genetics SGEN:US USD 23.86B 1.38B
Teva Pharmaceutical TEVA:IT USD 36.36B 5.59B
Ultragenyx Pharmaceutical RARE:US USD 3.25B 348M
United Therapeutics UTHR:US USD 12.68B 3.14B
Vertex Pharmaceuticals VRTX:US USD 74.13B 169M
YTE INCY:US USD 17.87B 3.05B